4//SEC Filing
Eichorn Laura G. 4
Accession 0001567619-22-022097
CIK 0001623715other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:07 PM ET
Size
9.2 KB
Accession
0001567619-22-022097
Insider Transaction Report
Form 4
Eichorn Laura G.
See Remarks
Transactions
- Sale
Common Stock
2022-12-27$35.93/sh−3,100$111,384→ 207,737 total - Exercise/Conversion
Common Stock
2022-12-27$2.52/sh+3,100$7,812→ 210,837 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-27−3,100→ 22,950 totalExercise: $2.52From: 2021-01-01Exp: 2027-03-28→ Common Stock (3,100 underlying)
Footnotes (1)
- [F1]The transaction was executed in multiple trades in prices ranging from $35.93 to $35.935, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Imago BioSciences, Inc.
CIK 0001623715
Entity typeother
Related Parties
1- filerCIK 0001861067
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:07 PM ET
- Size
- 9.2 KB